Missense mutations in the perforin (PRF1) gene as a cause of hereditary cancer predisposition
File(s)Chaudhry et al, OncoImmunology 2016.pdf (1.02 MB)
Accepted version
Author(s)
Type
Journal Article
Abstract
Perforin, a pore-forming toxin released from secretory granules of NK cells and
CTLs, is essential for their cytotoxic activity against infected or cancerous target
cells. Bi-allelic loss-of-function mutations in the perforin gene are invariably
associated with a fatal immunoregulatory disorder, familial haemophagocytic
lymphohistiocytosis type 2 (FHL2), in infants. More recently, it has also been
recognized that partial loss of perforin function can cause disease in later life,
including delayed onset FHL2 and haematological malignancies. Herein we
report a family in which a wide range of systemic inflammatory and neoplastic
manifestations have occurred across three generations. We found that disease
was linked to two missense perforin gene mutations (encoding A91V, R410W)
that cause protein misfolding and partial loss of activity. These cases link the
partial loss of perforin function with some solid tumours that are known to be
controlled by the immune system, as well as haematological cancers. Our
findings also demonstrate that perforin gene mutations can contribute to
hereditary cancer predisposition.
CTLs, is essential for their cytotoxic activity against infected or cancerous target
cells. Bi-allelic loss-of-function mutations in the perforin gene are invariably
associated with a fatal immunoregulatory disorder, familial haemophagocytic
lymphohistiocytosis type 2 (FHL2), in infants. More recently, it has also been
recognized that partial loss of perforin function can cause disease in later life,
including delayed onset FHL2 and haematological malignancies. Herein we
report a family in which a wide range of systemic inflammatory and neoplastic
manifestations have occurred across three generations. We found that disease
was linked to two missense perforin gene mutations (encoding A91V, R410W)
that cause protein misfolding and partial loss of activity. These cases link the
partial loss of perforin function with some solid tumours that are known to be
controlled by the immune system, as well as haematological cancers. Our
findings also demonstrate that perforin gene mutations can contribute to
hereditary cancer predisposition.
Date Issued
2016-06-30
Date Acceptance
2016-04-11
Citation
OncoImmunology, 2016, 5 (7)
ISSN
2162-402X
Publisher
Taylor & Francis
Journal / Book Title
OncoImmunology
Volume
5
Issue
7
Copyright Statement
This is an Accepted Manuscript of an article published by Taylor & Francis Group in OncoImmunology on 2 June 2016, available online at: http://www.tandfonline.com/10.1080/2162402X.2016.1179415
Publication Status
Published
Article Number
e1179415
Date Publish Online
2016-06-30